The latest CDC FluSurv-NET data for Week 11 (ending March 21, 2026) reports a cumulative laboratory-confirmed influenza hospitalization rate of 81.6 per 100,000 population—the third highest since the 2010–2011 season—with pediatric rates at 49.9 per 100,000, positioning trader consensus at 51% implied probability for 80–85 in Week 12. Weekly rates fell to 1.1 per 100,000 amid decreasing influenza A(H3N2) activity across most U.S. regions, corroborated by FluSight ensemble forecasts predicting further national declines in new hospital admissions through Week 14. Waning seasonal trends and low outpatient positivity (below 3%) limit additional cumulative growth, though reporting delays introduce minor uncertainty; the next FluView update will refine Week 12 figures.
Polymarketデータを参照したAI生成の実験的な要約 · 更新日Flu Hospitalization Rate Week 12, 2026?
Flu Hospitalization Rate Week 12, 2026?
95以上 9.8%
90–95 9%
85–90 5.5%
<75 2.5%
NEW
NEW
Apr 3, 2026
<75
2%
75–80
18%
80–85
59%
85–90
26%
90–95
9%
95以上
10%
95以上 9.8%
90–95 9%
85–90 5.5%
<75 2.5%
NEW
NEW
Apr 3, 2026
<75
$145 Vol.
2%
75–80
$171 Vol.
18%
80–85
$327 Vol.
59%
85–90
$158 Vol.
26%
90–95
$2,983 Vol.
9%
95以上
$110 Vol.
10%
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The latest CDC FluSurv-NET data for Week 11 (ending March 21, 2026) reports a cumulative laboratory-confirmed influenza hospitalization rate of 81.6 per 100,000 population—the third highest since the 2010–2011 season—with pediatric rates at 49.9 per 100,000, positioning trader consensus at 51% implied probability for 80–85 in Week 12. Weekly rates fell to 1.1 per 100,000 amid decreasing influenza A(H3N2) activity across most U.S. regions, corroborated by FluSight ensemble forecasts predicting further national declines in new hospital admissions through Week 14. Waning seasonal trends and low outpatient positivity (below 3%) limit additional cumulative growth, though reporting delays introduce minor uncertainty; the next FluView update will refine Week 12 figures.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
マーケット開始日： Mar 27, 2026, 11:13 AM ET
音量
$3,895終了日
Apr 3, 2026マーケット開始日
Mar 27, 2026, 11:13 AM ETResolver
0x69c47De9D...This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The latest CDC FluSurv-NET data for Week 11 (ending March 21, 2026) reports a cumulative laboratory-confirmed influenza hospitalization rate of 81.6 per 100,000 population—the third highest since the 2010–2011 season—with pediatric rates at 49.9 per 100,000, positioning trader consensus at 51% implied probability for 80–85 in Week 12. Weekly rates fell to 1.1 per 100,000 amid decreasing influenza A(H3N2) activity across most U.S. regions, corroborated by FluSight ensemble forecasts predicting further national declines in new hospital admissions through Week 14. Waning seasonal trends and low outpatient positivity (below 3%) limit additional cumulative growth, though reporting delays introduce minor uncertainty; the next FluView update will refine Week 12 figures.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
音量
$3,895終了日
Apr 3, 2026マーケット開始日
Mar 27, 2026, 11:13 AM ETResolver
0x69c47De9D...The latest CDC FluSurv-NET data for Week 11 (ending March 21, 2026) reports a cumulative laboratory-confirmed influenza hospitalization rate of 81.6 per 100,000 population—the third highest since the 2010–2011 season—with pediatric rates at 49.9 per 100,000, positioning trader consensus at 51% implied probability for 80–85 in Week 12. Weekly rates fell to 1.1 per 100,000 amid decreasing influenza A(H3N2) activity across most U.S. regions, corroborated by FluSight ensemble forecasts predicting further national declines in new hospital admissions through Week 14. Waning seasonal trends and low outpatient positivity (below 3%) limit additional cumulative growth, though reporting delays introduce minor uncertainty; the next FluView update will refine Week 12 figures.
Polymarketデータを参照したAI生成の実験的な要約 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問